Maxfort Pharmaceuticals Private Limited
About Maxfort Pharmaceuticals Private Limited
Data last updated:
Maxfort Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 05 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85100UP2014PTC064186. Its GSTIN is 09AAJCM2405K1ZD (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aliza Jafar and Agha Jafar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Basement Shop No. – 03 Dayal Complex S – 139 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.31 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹6.8 Lakh (net margin -5.2%) and EBITDA of -₹6.71 Lakh (EBITDA margin -5.1%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBasement Shop No. – 03 Dayal Complex S – 139 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Maxfort Pharmaceuticals Private Limited
The main business activity of Maxfort Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Maxfort Pharmaceuticals Private Limited FY 2025 filings available
Maxfort Pharmaceuticals Private Limited reported revenue of ₹1.31 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Maxfort Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 23% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maxfort Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹6.71 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.8 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maxfort Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -5.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxfort Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Maxfort Pharmaceuticals Private Limited
Maxfort Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bebblin Pharmaceuticals Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Ranchi, Jharkhand, India |
| Ensure Pharmaceuticals Private Limited | ₹1.31 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Aurangabad, Maharashtra, India |
| Sevenocean Pharmaceuticals and Marketing Private Limited | ₹1.31 Cr (FY 2025) | •••• | •••• | 90.0% | •••• | Chikodi, Karnataka, India |
| Mecoson Pharmaceuticals Private Limited | ₹1.31 Cr (FY 2024) | •••• | •••• | 1898.0% | •••• | Surat, Gujarat, India |
| Likha Pharmaceuticals Private Limited | ₹1.31 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Bangalore, Karnataka, India |
| Maxfort Pharmaceuticals Private Limited this company | ₹1.31 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Lucknow, Uttar Pradesh, India |
| Daaso Pharmaceuticals Private Limited | ₹1.31 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Nagpur, Maharashtra, India |
| Zriza Pharmaceuticals Private Limited | ₹1.31 Cr (FY 2024) | •••• | •••• | -21.0% | •••• | Bangalore, Karnataka, India |
| Denz Pharmaceuticals Private Limited | ₹1.3 Cr (FY 2019) | •••• | •••• | 2151.0% | •••• | Kanpur, Uttar Pradesh, India |
| Indian Organics and Pharmaceuticals Pvt Ltd | ₹1.3 Cr (FY 2025) | •••• | •••• | 110.0% | •••• | Indore, Madhya Pradesh, India |
| Klintoz Pharmaceuticals Private Limited | ₹1.3 Cr (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Maxfort Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Maxfort Pharmaceuticals Private Limited
Maxfort Pharmaceuticals Private Limited is audited by SANTOSH KUMAR TRIPATHI for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SANTOSH KUMAR TRIPATHI | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Maxfort Pharmaceuticals Private Limited
Maxfort Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aliza Jafar | Director | 23 Mar 2022 | 4 Years 6 Months | Current |
| Agha Jafar | Director | 05 Jun 2014 | 12 Years 4 Months | Current |
Ownership and Shareholding of Maxfort Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maxfort Pharmaceuticals Private Limited
Maxfort Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Maxfort Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Maxfort Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxfort Pharmaceuticals Private Limited
Maxfort Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Pankaj Manmohan Das Shah ceased to be Director on 24 Mar 2022.
Credit Ratings, Litigation & Regulatory Alerts for Maxfort Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxfort Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxfort Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxfort Pharmaceuticals Private Limited
Maxfort Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAJCM2405K1ZD | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxfort Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxfort Pharmaceuticals Private Limited
Maxfort Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 05 June 2014 (12+ years old) and is registered under CIN U85100UP2014PTC064186.
Maxfort Pharmaceuticals reported revenue of ₹1.31 Cr for FY 2025 (up 23% YoY).
Maxfort Pharmaceuticals has 2 current directors:
- Aliza Jafar - Director
- Agha Jafar - Director
Maxfort Pharmaceuticals reported a net loss of ₹6.8 Lakh (net margin -5.2%) and EBITDA of -₹6.71 Lakh (EBITDA margin -5.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maxfort Pharmaceuticals is 52% over three years and 3% over five years. In the latest year (FY 2025) revenue rose 23%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maxfort Pharmaceuticals is 09AAJCM2405K1ZD, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Maxfort Pharmaceuticals is U85100UP2014PTC064186. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxfort Pharmaceuticals was incorporated on 05 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Maxfort Pharmaceuticals by revenue are Bebblin Pharmaceuticals Private Limited, Ensure Pharmaceuticals Private Limited, Sevenocean Pharmaceuticals and Marketing Private Limited, Mecoson Pharmaceuticals Private Limited, Likha Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Pankaj Manmohan Das Shah ceased to be Director on 24 Mar 2022. Aliza Jafar was appointed as Director on 23 Mar 2022. Agha Jafar was appointed as Director on 05 Jun 2014.
The registered office of Maxfort Pharmaceuticals is at Basement Shop No. – 03 Dayal Complex S – 139 Transport Nagar Kanpur Road, Lucknow, Uttar Pradesh, India – 226012.